We are live on ! Find out more
PALI icon

Palisade Bio
PALI

7 hedge funds and large institutions have $7.85M invested in Palisade Bio in 2017 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 1 increasing their positions, reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

309% more capital invested

Capital invested by funds: $1.92M → $7.85M (+$5.93M)

174% more call options, than puts

Call options by funds: $743K | Put options by funds: $271K

133% more funds holding

Funds holding: 3 → 7 (+4)

0% more ownership

Funds ownership: 0% → 0% (+0%)

Holders
7
Holders Change
+4
Holders Change %
+133.33%
% of All Funds
0.17%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
1
Reduced
–
Closed
–
Calls
$743K
Puts
$271K
Net Calls
+$472K
Net Calls Change
+$472K

Top Buyers

Rank Fund Capital Flow
1
SM
Sabby Management
Florida
+$2.29M
2
ACM
Alethea Capital Management
Washington
+$763K
3
BlackRock
BlackRock
New York
+$381K
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$381K
5
Vanguard Group
Vanguard Group
Pennsylvania
+$381K

Top Sellers

Rank Fund Capital Flow
1
Bank of New York Mellon
Bank of New York Mellon
New York
-$25K
2
GC
Guggenheim Capital
Illinois
-$14K
3
State Street
State Street
Massachusetts
-$12K
4
FA
FCG Advisors
New Jersey
-$6K
5
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors
Iowa
-$4K
Name Holding Trade Value Shares
Change 		Change in
Stake
SM
1
Sabby Management
Florida
$2.72M +$2.29M +6 New
Vanguard Group
2
Vanguard Group
Pennsylvania
$1.8M +$381K +1 +33%
ACM
3
Alethea Capital Management
Washington
$868K +$763K +2 New
Susquehanna International Group
4
Susquehanna International Group
Pennsylvania
$470K +$381K +1 New
Geode Capital Management
5
Geode Capital Management
Massachusetts
$417K – – –
BlackRock
6
BlackRock
New York
$410K +$381K +1 New
VKH
7
Virtu KCG Holdings
New York
$361K +$381K +1 New
William Blair & Company
8
William Blair & Company
Illinois
$149K – – –
BRWA
9
B. Riley Wealth Advisors
Florida
$112K – – –
Commonwealth Equity Services
10
Commonwealth Equity Services
Massachusetts
$106K – – –
Northern Trust
11
Northern Trust
Illinois
$106K – – –
California Public Employees Retirement System
12
California Public Employees Retirement System
California
$63K – – –
Millennium Management
13
Millennium Management
New York
$62K – – –
Fifth Third Bancorp
14
Fifth Third Bancorp
Ohio
$49K – – –
UBS Group
15
UBS Group
Switzerland
$32K – – –
Wells Fargo
16
Wells Fargo
California
$30K – – –
PNC Financial Services Group
17
PNC Financial Services Group
Pennsylvania
$28K – – –
LTFS
18
Ladenburg Thalmann Financial Services
Florida
$15K – – –
FO
19
FT Options
Illinois
$14K – – –
Morgan Stanley
20
Morgan Stanley
New York
$13K – – –
DC
21
Davenport & Co
Virginia
$6.56K – – –
Bank of America
22
Bank of America
North Carolina
$3K – – –
FSCM
23
Front Street Capital Management
Montana
$3K – – –
Creative Planning
24
Creative Planning
Kansas
$2K – – –
Royal Bank of Canada
25
Royal Bank of Canada
Ontario, Canada
$2K – – –
1
2

PALI Hedge Fund Activity: Q1 2017 in Review

7 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in Palisade Bio (PALI) for Q1 2017, worth a combined $7.85M — up 309% from $1.92M a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new PALI positions and 0 closed out — a net gain of 5 holders — while 1 added to existing stakes and 0 trimmed.

The largest buyer was Sabby Management, opening a new position worth an estimated $2.29M. The largest seller was Bank of New York Mellon, cutting an estimated $25K.

  • 7 institutional investors held Palisade Bio (PALI) as of Q1 2017, up from 3 in Q4 2016.
  • Funds reported $7.85M of Palisade Bio stock for Q1 2017, up 309% quarter-over-quarter.
  • 5 funds opened new Palisade Bio positions in Q1 2017 and 0 closed out, a net change of +5 holders.
  • The largest Palisade Bio buyer in Q1 2017 was Sabby Management, an estimated $2.29M added.
  • The largest Palisade Bio seller in Q1 2017 was Bank of New York Mellon, an estimated $25K sold.

Based on aggregated 13F filings for Q1 2017.